| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.093 | 0.6 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | 0.06 | 0.6 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.064 | 0.6 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.7 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.015 | 0.7 |